Profender Tablets and Spot-on Solutions Update: Adverse Event Details Revised
Learn about the changes made to the Summary of Product Characteristics (SPC) for Profender pet products, including modified-release tablets and spot-on solutions.
Profender, a popular line of veterinary products, has recently updated the information provided on adverse events in the Summary of Product Characteristics (SPC) for its modified-release tablets, spot-on solutions, and multi-dose spot-on solutions. This change aims to provide more comprehensive and transparent details about potential side effects associated with the use of these Profender products.
The updated SPC includes additional information on the adverse events that have been reported during the post-marketing surveillance of Profender products. This includes details on the frequency, severity, and nature of the reported side effects, which can help veterinarians and pet owners make more informed decisions about the use of these products.
The changes to the SPC are part of the ongoing commitment of the Profender manufacturer to provide comprehensive and up-to-date information about the safety and efficacy of their products. By continuously monitoring the performance of their products in the real-world setting and updating the SPC accordingly, the company aims to ensure that veterinarians and pet owners have access to the most accurate and reliable information to guide their treatment decisions.
Veterinarians and pet owners are encouraged to review the updated SPC for Profender products to familiarize themselves with the newly added information on adverse events. This will help them make informed decisions about the appropriate use of these products and ensure the best possible outcomes for the pets under their care.
In conclusion, the changes to the SPC for Profender products demonstrate the manufacturer's dedication to transparency and their commitment to continuously improving the safety and efficacy of their products. By providing veterinarians and pet owners with more detailed information on potential adverse events, the company aims to empower them to make informed decisions that prioritize the health and wellbeing of their pets.
Source: UK Government
